Why the MIND Study Matters: Building Clinical Trial Readiness for MED13L with Abigail Svedeen, MS, CGC
Why the MIND Study Matters: Building Clinical Trial Readiness for MED13L
In this powerful and informative episode of Voices of MED13L, Vanessa sits down with Abigail Sveden, MS, CGC, a genetic counselor at the Boston Children's Hospital and member of the Rosamund Stone Zander Translational Neuroscience Center (TNC).
Together, they unpack the critical importance of the MIND Study — MED13L Syndrome Investigation of Natural History and Development — and what it means for families today and for the future of therapeutics.
🧬 What You'll Learn in This Episode:
What translational neuroscience really means — and how lab discoveries move toward real-world treatmentsWhy natural history studies are essential for clinical trial readinessHow longitudinal data helps researchers understand development over timeThe role of neurobehavioral assessments (including the Vineland) in FDA-approved outcome measuresWhy standardized data collection is critical for future therapeuticsNew clinical observations emerging from the MED13L cohortHow participation today helps prevent future families from facing a “Google search diagnosis”Abigail shares how the TNC brings together experts in genetics, neurodevelopment, EEG, regulatory science, and basic research — all working toward one goal: improving outcomes for individuals with rare neurodevelopmental disorders like MED13L.
Vanessa also speaks candidly about the parent experience — the emotional weight of surveys, the importance of being heard, and why documenting your child’s story is one of the most powerful contributions you can make to the community.
📊 MIND Study Snapshot
🎯 Goal enrollment: 30 participants✅ 27 fully enrolled📈 24 have completed Year One components🔁 Annual follow-up is critical for longitudinal data📍 In-person visits at Boston Children’s Hospital prioritized (virtual options available)Participation includes:
Interview-style visits with the study teamNeurobehavioral assessmentsStandardized questionnaires (including the Vineland)Medical record reviewOptional photo and biospecimen contributionThis data builds the foundation for:
Clinical trial readinessFDA-accepted outcome measuresPublished research to educate physicians worldwideFuture therapeutic development💛 Why It Matters
Every story matters — especially in rare disease.
Participation helps:
Define what MED13L looks like across the lifespanIdentify patterns in development, seizures, puberty, motor differences, and moreInform physicians so families are no longer handed a Google printoutBuild the roadmap toward future treatmentsHope is built on data.
Data is built by families.
🔬 Additional Research Opportunities
If the MIND Study is full, there are other ways to participate:
MED13L Census (homepage of med13l.org)Simons SearchlightRare-XCitizen Health (5-minute registration that helps collect medical records)Links are available on the MED13L Foundation research page and below.
📩 Interested in the MIND Study?
To learn more or inquire about participation, contact:
Abigail Sveden, MS, CGC
📧
[email protected]
Support the show
Resources
Strides for Stripes: Move for Mito | Pledgestar campaign
Denver Mini-Conference: Get your tickets
MED13L Awareness Campaign: https://secure.qgiv.com/event/med13lfoundationp2p/
Profile Frame for Socials
Community Enrollment Form
Community Checklist: Google Drive Link
CRID: thecrid.org
Citizen Health: citizen.health/partners/med13l-foundation
Simons Searchlight: https://research.simonssearchlight.org/account/create
Rare-X: rare-x.org/med13l
Link Tree: List of Resources
Website: med13l.org
Facebook: facebook.com/med13lfoundation
Instagram: instagram.com/med13lfou...